Yuemei Feng
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A potentially effective drug for patients with recurrent glioma: sermorelin.
Journal: Annals of translational medicine
Published: April 12, 2021
Uronic acid metabolic process-related gene expression-based signature predicts overall survival of glioma.
Journal: Bioscience reports
Published: September 01, 2020
Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis.
Journal: Frontiers in immunology
Published: July 08, 2020
Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma.
Journal: Frontiers in immunology
Published: July 07, 2020
A novel DNA repair-related nomogram predicts survival in low-grade gliomas.
Journal: CNS neuroscience & therapeutics
Published: June 30, 2020
A novel methylation signature predicts radiotherapy sensitivity in glioma.
Journal: Scientific reports
Published: May 14, 2020
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma.
Journal: Aging
Published: January 29, 2020
Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages.
Journal: Cancer medicine
Published: June 27, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026